The largest community of pharma leaders

Moderna says UK deal will supply COVID-19 vaccine from March

(Reuters) – Moderna Inc MRNA.O confirmed on Tuesday it had agreed to supply its COVID-19 vaccine candidate, mRNA-1273, to the United Kingdom starting from the beginning of March, as long as it succeeds in gaining local regulatory approval.

The company’s statement did not disclose other terms of the agreement, including the number of doses it agreed to supply.


Recent Articles